The secret of the story
Products that began with an angel
It all began when Lilly, the second child of Alpaderm’s founders, was born. Starting when she was just a few months old, she was plagued with severe atopic dermatitis. Paediatricians prescribed strong doses of cortisone cream to fight against the incessant burning sensations and to calm her suffering.
Given the difficulty of administering the most common skin treatments on Lilly, her parents conducted meticulous research to find possible causes for their child’s eczema. They were able to rule out allergens in both her food and environment. They were also dismayed to discover an abundance of synthetic chemical products in the most frequently-used treatments, particularly in products used for infants.
With a PhD in Pharmaceutical Sciences from the University of Paris, and a biology degree from the University of California, Berkeley (the heart of the ecology movement), France BOURELY has always been fascinated by the power of plants and essential oils. With her qualifications, it was only logical for her to decide to make a soothing moisturising cream for her daughter, using an association of the ultimate all-organic ingredients that nature has to offer. France patiently conducted extensive research in every possible scientific database in order to develop her formulas, both seeking the traditional properties of each ingredient and making sure that they were as non-allergenic as possible.
For example, most people don’t know that babies are relatively allergic to rosewater. Yet this ingredient is found in numerous preparations. France BOURELY was thus able to choose from among the long-known oils and ingredients in Europe that have been associated with baby care for many years, in order to identify those most likely to clean, sooth, and calm a baby’s skin, while protecting its fragile nature. This is how precious primrose, borage, jojoba and many other oils that penetrate deeply to nourish the skin, have become the privileged ingredients of the Alpaderm brand.
This post is also available in: French